Aberrant expression of SLC25A21 influenced AML cell biological behavior of both in vitro and in vivo, inhibiting cell proliferation, inducing G0/G1 arrest, and promoting apoptosis. Here, SLC25A21 is linked to acute myeloid leukemia.